{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T02:00:28Z","timestamp":1769479228850,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T00:00:00Z","timestamp":1766448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T00:00:00Z","timestamp":1769385600000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-12407-y","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:55:35Z","timestamp":1766458535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of autoantibody responses in COVID-19 patients: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Dan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,23]]},"reference":[{"key":"12407_CR1","doi-asserted-by":"publisher","unstructured":"Gracia-Ramos AE, Martin-Nares E, Hern\u00e1ndez-Molina G. New onset of autoimmune diseases following COVID-19 diagnosis. Cells. 2021;10(12). https:\/\/doi.org\/10.3390\/cells10123592.","DOI":"10.3390\/cells10123592"},{"issue":"6","key":"12407_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/cts.12805","volume":"13","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Han T, Chen J, Hou C, Hua L, He S, et al. Clinical and autoimmune characteristics of severe and critical cases of COVID-19. Clin Transl Sci. 2020;13(6):1077\u201386. https:\/\/doi.org\/10.1111\/cts.12805.","journal-title":"Clin Transl Sci"},{"issue":"9","key":"12407_CR3","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s11926-021-01041-7","volume":"23","author":"M Stelzer","year":"2021","unstructured":"Stelzer M, Henes J, Saur S. The role of antiphospholipid antibodies in COVID-19. Curr Rheumatol Rep. 2021;23(9):72. https:\/\/doi.org\/10.1007\/s11926-021-01041-7.","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"12407_CR4","doi-asserted-by":"publisher","first-page":"102743","DOI":"10.1016\/j.autrev.2020.102743","volume":"20","author":"ZX Xiao","year":"2021","unstructured":"Xiao ZX, Miller JS, Zheng SG. An updated advance of autoantibodies in autoimmune diseases. Autoimmun Rev. 2021;20(2):102743. https:\/\/doi.org\/10.1016\/j.autrev.2020.102743.","journal-title":"Autoimmun Rev"},{"issue":"3","key":"12407_CR5","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1365-2249.2005.02864.x","volume":"141","author":"YS Lin","year":"2005","unstructured":"Lin YS, Lin CF, Fang YT, Kuo YM, Liao PC, Yeh TM, et al. Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. Clin Exp Immunol. 2005;141(3):500\u201308. https:\/\/doi.org\/10.1111\/j.1365-2249.2005.02864.x.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"12407_CR6","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00296-020-04639-9","volume":"40","author":"S Shah","year":"2020","unstructured":"Shah S, Danda D, Kavadichanda C, Das S, Adarsh MB, Negi VS. Autoimmune and rheumatic musculoskeletal diseases as a consequence of SARS-CoV-2 infection and its treatment. Rheumatol Int. 2020;40(10):1539\u201354. https:\/\/doi.org\/10.1007\/s00296-020-04639-9.","journal-title":"Rheumatol Int"},{"key":"12407_CR7","doi-asserted-by":"publisher","first-page":"109183","DOI":"10.1016\/j.intimp.2022.109183","volume":"112","author":"M Vahabi","year":"2022","unstructured":"Vahabi M, Ghazanfari T, Sepehrnia S. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection. Int Immunopharmacol. 2022;112:109183. https:\/\/doi.org\/10.1016\/j.intimp.2022.109183.","journal-title":"Int Immunopharmacol"},{"key":"12407_CR8","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.jtauto.2021.100091","volume":"4","author":"JM Anaya","year":"2021","unstructured":"Anaya JM, Monsalve DM, Rojas M, Rodr\u00edguez Y, Montoya-Garc\u00eda N, Mancera-Navarro LM, et al. Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19. J Transl Autoimmun. 2021;4:100091. https:\/\/doi.org\/10.1016\/j.jtauto.2021.100091.","journal-title":"J Transl Autoimmun"},{"issue":"7","key":"12407_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/vox.13439","volume":"118","author":"D Blickstein","year":"2023","unstructured":"Blickstein D, Izak M, Filipovich-Rimon T, Garach-Jehoshua O, Rahimi-Levene N, Shinar E, et al. Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19 infection. Vox Sang. 2023;118(7):517\u201322. https:\/\/doi.org\/10.1111\/vox.13439.","journal-title":"Vox Sang"},{"issue":"1","key":"12407_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14397595.2021.1892257","volume":"32","author":"S Karahan","year":"2022","unstructured":"Karahan S, Erol K, Yuksel RC, Artan C, Celik I. Antiphospholipid antibodies in COVID-19-associated pneumonia patients in intensive care unit. Mod Rheumatol. 2022;32(1):163\u201368. https:\/\/doi.org\/10.1080\/14397595.2021.1892257.","journal-title":"Mod Rheumatol"},{"issue":"5","key":"12407_CR11","doi-asserted-by":"publisher","first-page":"e13313","DOI":"10.1111\/sji.13313","volume":"98","author":"P Koz\u0142owski","year":"2023","unstructured":"Koz\u0142owski P, Lulek M, Skwarek A, \u015amiarowski M, Ma\u0142ecka-Gie\u0142dowska M, Ciepiela O. Mild-to-moderate COVID-19 does not predispose to the development of autoimmune rheumatic diseases or autoimmune-based thrombosis. Scand J Immunol. 2023;98(5):e13313. https:\/\/doi.org\/10.1111\/sji.13313.","journal-title":"Scand J Immunol"},{"key":"12407_CR12","doi-asserted-by":"publisher","first-page":"100073","DOI":"10.1016\/j.jtauto.2020.100073","volume":"3","author":"LA Lerma","year":"2020","unstructured":"Lerma LA, Chaudhary A, Bryan A, Morishima C, Wener MH, Fink SL. Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19). J Transl Autoimmun. 2020;3:100073. https:\/\/doi.org\/10.1016\/j.jtauto.2020.100073.","journal-title":"J Transl Autoimmun"},{"key":"12407_CR13","doi-asserted-by":"publisher","unstructured":"Mellor-Pita S, Tutor-Ureta P, Velasco P, Plaza A, Diego I, V\u00e1zquez-Comendador J, et al. IgA anti-\u03b22-glycoprotein I antibodies as markers of thrombosis and severity in COVID-19 patients. Viruses. 2024;16(7). https:\/\/doi.org\/10.3390\/v16071071.","DOI":"10.3390\/v16071071"},{"issue":"2","key":"12407_CR14","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/cts.12908","volume":"14","author":"S Pascolini","year":"2021","unstructured":"Pascolini S, Vannini A, Deleonardi G, Ciordinik M, Sensoli A, Carletti I, et al. COVID-19 and immunological dysregulation: can autoantibodies be useful? Clin Transl Sci. 2021;14(2):502\u201308. https:\/\/doi.org\/10.1111\/cts.12908.","journal-title":"Clin Transl Sci"},{"key":"12407_CR15","doi-asserted-by":"publisher","first-page":"113174","DOI":"10.1016\/j.jim.2021.113174","volume":"499","author":"BO Peker","year":"2021","unstructured":"Peker BO, \u015eener AG, Kaptan Aydo\u011fmu\u015f F. Antinuclear antibodies (ANAs) detected by indirect immunofluorescence (IIF) method in acute COVID-19 infection; future roadmap for laboratory diagnosis. J Immunol Methods. 2021;499:113174. https:\/\/doi.org\/10.1016\/j.jim.2021.113174.","journal-title":"J Immunol Methods"},{"issue":"5","key":"12407_CR16","doi-asserted-by":"publisher","first-page":"e1276","DOI":"10.1002\/iid3.1276","volume":"12","author":"SA Roghani","year":"2024","unstructured":"Roghani SA, Dastbaz M, Lotfi R, Shamsi A, Abdan Z, Rostampour R, et al. The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19. Immun Inflamm Dis. 2024;12(5):e1276. https:\/\/doi.org\/10.1002\/iid3.1276.","journal-title":"Immun Inflamm Dis"},{"issue":"3","key":"12407_CR17","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/cts.12953","volume":"14","author":"MC Sacchi","year":"2021","unstructured":"Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A, et al. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci. 2021;14(3):898\u2013907. https:\/\/doi.org\/10.1111\/cts.12953.","journal-title":"Clin Transl Sci"},{"issue":"8","key":"12407_CR18","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1111\/all.15302","volume":"77","author":"P Taeschler","year":"2022","unstructured":"Taeschler P, Cervia C, Zurbuchen Y, Hasler S, Pou C, Tan Z, et al. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy. 2022;77(8):2415\u201330. https:\/\/doi.org\/10.1111\/all.15302.","journal-title":"Allergy"},{"issue":"9","key":"12407_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/annrheumdis-2021-220206","volume":"80","author":"U Trahtemberg","year":"2021","unstructured":"Trahtemberg U, Rottapel R, Dos Santos CC, Slutsky AS, Baker A, Fritzler MJ. Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients. Ann Rheum Dis. 2021;80(9):1236\u201340. https:\/\/doi.org\/10.1136\/annrheumdis-2021-220206.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"12407_CR20","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3760\/cma.j.cn114452-20220506-00270","volume":"45","author":"Z Bokun","year":"2022","unstructured":"Bokun Z, Yueting T, Gui Y, Yunbao P, Yirong L. Expression characteristic of autoantibodies and association with outcome in COVID-19 patients. Chin J Lab Med. 2022;45(12):1259\u201366. https:\/\/doi.org\/10.3760\/cma.j.cn114452-20220506-00270.","journal-title":"Chin J Lab Med"},{"key":"12407_CR21","doi-asserted-by":"publisher","first-page":"100175","DOI":"10.1016\/j.jtauto.2022.100175","volume":"5","author":"S Zhou","year":"2022","unstructured":"Zhou S, Kaul R, Lynch KL, Wu AHB, Walker RP. Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection. J Transl Autoimmun. 2022;5:100175. https:\/\/doi.org\/10.1016\/j.jtauto.2022.100175.","journal-title":"J Transl Autoimmun"},{"key":"12407_CR22","doi-asserted-by":"publisher","first-page":"e14927","DOI":"10.1590\/1414-431X2025e14927","volume":"58","author":"EMB Hi","year":"2025","unstructured":"Hi EMB, Bianchi CCR, Gritte RB, Klauss PHA, Leal N, Oliveira IS, Barros M, Soriano FG, Curi R, Machado MCC. Detection of autoantibodies in severe COVID-19 patients two years after hospital discharge. Braz J Med Biol Res. 2025;58:e14927. https:\/\/doi.org\/10.1590\/1414-431X2025e14927.","journal-title":"Braz J Med Biol Res"},{"key":"12407_CR23","doi-asserted-by":"publisher","first-page":"1593577","DOI":"10.3389\/fimmu.2025.1593577","volume":"16","author":"H Huang","year":"2025","unstructured":"Huang H, Zang YJ, Li ZG, Li Q, Ma CY, Zhao HY, Li H. Correlation between severe acute respiratory syndrome coronavirus 2 infection and serum anti-neutrophil cytoplasmic antibody formation. Front Immunol. 2025;16:1593577. https:\/\/doi.org\/10.3389\/fimmu.2025.1593577.","journal-title":"Front Immunol"},{"key":"12407_CR24","doi-asserted-by":"publisher","unstructured":"Shams Aldeen M, Logman Masaad M, Azhary A, Suliman A, Alziber MA, MohammedAhmed M, et al. The presence of antineutrophil cytoplasmic antibodies and antiphospholipid antibodies in patients with severe acute respiratory syndrome coronavirus, 2: a case-control study among Sudanese patients. Interdiscip Perspect Infect Dis. 2022;2022:6511198. https:\/\/doi.org\/10.1155\/2022\/6511198.","DOI":"10.1155\/2022\/6511198"},{"issue":"4","key":"12407_CR25","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s12026-023-09371-7","volume":"71","author":"N Saeedi","year":"2023","unstructured":"Saeedi N, Gohari NSF, Ghalibaf AAM, Dehghan A, Owlia MB. COVID-19 infection: a possible induction factor for development of autoimmune diseases? Immunol Res. 2023;71(4):547\u201353. https:\/\/doi.org\/10.1007\/s12026-023-09371-7.","journal-title":"Immunol Res"},{"issue":"4","key":"12407_CR26","doi-asserted-by":"publisher","first-page":"102792","DOI":"10.1016\/j.autrev.2021.102792","volume":"20","author":"A Dotan","year":"2021","unstructured":"Dotan A, Muller S, Kanduc D, David P, Halpert G, Shoenfeld Y. The SARS-CoV-2 as an instrumental trigger of autoimmunity. Autoimmun Rev. 2021;20(4):102792. https:\/\/doi.org\/10.1016\/j.autrev.2021.102792.","journal-title":"Autoimmun Rev"},{"issue":"1","key":"12407_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s12985-023-02191-z","volume":"20","author":"SJ Lee","year":"2023","unstructured":"Lee SJ, Yoon T, Ha JW, Kim J, Lee KH, Lee JA, et al. Prevalence, clinical significance, and persistence of autoantibodies in COVID-19. Virol J. 2023;20(1):236. https:\/\/doi.org\/10.1186\/s12985-023-02191-z.","journal-title":"Virol J"},{"issue":"5","key":"12407_CR28","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1309\/ajcp6r8eelgodayw","volume":"135","author":"SS Copple","year":"2011","unstructured":"Copple SS, Sawitzke AD, Wilson AM, Tebo AE, Hill HR. Enzyme-linked immunosorbent assay screening then indirect immunofluorescence confirmation of antinuclear antibodies: a statistical analysis. Am J Clin Pathol. 2011;135(5):678\u201384. https:\/\/doi.org\/10.1309\/ajcp6r8eelgodayw.","journal-title":"Am J Clin Pathol"},{"key":"12407_CR29","doi-asserted-by":"publisher","unstructured":"Zuo Y, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med. 2020;12(570). https:\/\/doi.org\/10.1126\/scitranslmed.abd3876.","DOI":"10.1126\/scitranslmed.abd3876"},{"key":"12407_CR30","doi-asserted-by":"publisher","unstructured":"Knight JS, Caricchio R, Casanova JL, Combes AJ, Diamond B, Fox SE, et al. The intersection of COVID-19 and autoimmunity. J Clin Invest. 2021;131(24). https:\/\/doi.org\/10.1172\/jci154886.","DOI":"10.1172\/jci154886"},{"key":"12407_CR31","doi-asserted-by":"publisher","first-page":"584241","DOI":"10.3389\/fimmu.2020.584241","volume":"11","author":"MO Borghi","year":"2020","unstructured":"Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, et al. Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol. 2020;11:584241. https:\/\/doi.org\/10.3389\/fimmu.2020.584241.","journal-title":"Front Immunol"},{"issue":"17","key":"12407_CR32","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1056\/NEJMc2007575","volume":"382","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, et al. Coagulopathy and antiphospholipid antibodies in patients with covid-19. N Engl J Med. 2020;382(17):e38. https:\/\/doi.org\/10.1056\/NEJMc2007575.","journal-title":"N Engl J Med"},{"issue":"2","key":"12407_CR33","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1007\/s11239-021-02470-y","volume":"52","author":"V Pavoni","year":"2021","unstructured":"Pavoni V, Gianesello L, Horton A. Antiphospholipid antibodies in critically ill COVID-19 patients with thromboembolism: cause of disease or epiphenomenon? J Thromb Thrombolysis. 2021;52(2):542\u201352. https:\/\/doi.org\/10.1007\/s11239-021-02470-y.","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"12407_CR34","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1007\/s00296-021-04914-3","volume":"41","author":"T Izci Duran","year":"2021","unstructured":"Izci Duran T, Turkmen E, Dilek M, Sayarlioglu H, Arik N. ANCA-associated vasculitis after COVID-19. Rheumatol Int. 2021;41(8):1523\u201329. https:\/\/doi.org\/10.1007\/s00296-021-04914-3.","journal-title":"Rheumatol Int"},{"key":"12407_CR35","doi-asserted-by":"publisher","unstructured":"Frasca D, Reidy L, Romero M, Diaz A, Cray C, Kahl K, et al. The majority of SARS-CoV-2-specific antibodies in COVID-19 patients with obesity are autoimmune and not neutralizing. Int J Obes. 2022;46(2):427\u201332. https:\/\/doi.org\/10.1038\/s41366-021-01016-9.","DOI":"10.1038\/s41366-021-01016-9"},{"key":"12407_CR36","doi-asserted-by":"publisher","first-page":"152025","DOI":"10.1016\/j.semarthrit.2022.152025","volume":"55","author":"M Di Iorio","year":"2022","unstructured":"Di Iorio M, Cook CE, Vanni KMM, Patel NJ, D\u2019Silva KM, Fu X, et al. DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: a prospective study. Semin Arthritis Rheum. 2022;55:152025. https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152025.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"12407_CR37","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/rheumatology\/keab611","volume":"61","author":"T Schioppo","year":"2022","unstructured":"Schioppo T, Argolini LM, Sciascia S, Pregnolato F, Tamborini F, Miraglia P, et al. Clinical and peculiar immunological manifestations of SARS-CoV-2 infection in systemic lupus erythematosus patients. Rheumatol (Oxford). 2022;61(5):1928\u201335. https:\/\/doi.org\/10.1093\/rheumatology\/keab611.","journal-title":"Rheumatol (Oxford)"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-12407-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-12407-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T15:39:41Z","timestamp":1769441981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-12407-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,23]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12407"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-12407-y","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,23]]},"assertion":[{"value":"5 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}